The examination of appropriate switching dose of epoetin beta pegol from short-acting epoetin in the treatment of anemia in the patients on chronic hemodialysis.

The examination of appropriate switching dose of epoetin beta pegol from short-acting epoetin in the treatment of anemia in the patients on chronic hemodialysis. - The examination of switching dose of epoetin beta pegol

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007839

Enrollment

Registered

2012-05-01

Start date

2012-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients on chronic hemodialysis

Interventions

Pre-switching dose of epoetin is less than or equal to 4500 units/week

switch to 75 microgram once a month Pre-switching dose of epoetin 4500&lt

and less than or equal to 9000 units/week

switch to 150 microgram once a month Pre-switching dose of epoetin &gt

9000 units/week

switch to 225 microgram once a month

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1 Patients who maintained target hemoglobin level, which is defined by the guideline of he Japanese Society of Dialysis and Transplantation, for more than three consecutive months 2 Patients who are given short-acting epoetin for longer than three months and their doses were not changed for three consecutive months before switching 3 The patients who are 20 years old or older than 20 years old, and 75 years old or younger than 75years old

Exclusion criteria

Exclusion criteria: Patients with severe heart failure Patients who can not be obtained written informed consent

Design outcomes

Primary

Measure	Time frame
Hemoglobin concentration, dose of epoetin beta pegol	—

Countries

Japan

Contacts

Public ContactMatsuhiko Hayashi

Keio University, School of Medicine Apheresis and Dialysis Center

matuhiko@z3.keio.jp03-5363-3908

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026